TrialAdvances in respiratory medicine2023

Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.

Atefeh Vaezi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.